Cargando…
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
BACKGROUND: Encouraged by the goal of developing an effective treatment strategy for prostate cancer, this study explored the mechanism involved in metformin-mediated inhibition of AR-negative prostate cancer. METHODS: Cell behaviors of DU145 and PC3 cells were determined by CCK8 test, colony format...
Autores principales: | Chen, Chunyang, Wang, He, Geng, Xinyu, Zhang, Dongze, Zhu, Zhengyu, Zhang, Guangbo, Hou, Jianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369631/ https://www.ncbi.nlm.nih.gov/pubmed/34399755 http://dx.doi.org/10.1186/s12935-021-02043-2 |
Ejemplares similares
-
Blocking AMPK/ULK1-dependent autophagy promoted apoptosis and suppressed colon cancer growth
por: Liu, Jing, et al.
Publicado: (2019) -
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
por: Liu, Yuyang, et al.
Publicado: (2019) -
The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
por: Geng, Xinyu, et al.
Publicado: (2020) -
Nicotinamide N-methyltransferase inhibits autophagy induced by oxidative stress through suppressing the AMPK pathway in breast cancer cells
por: Yu, Haitao, et al.
Publicado: (2020) -
CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways
por: Yang, Suzhen, et al.
Publicado: (2022)